News and Insights of 3D Printing and Manufacturing
After joining the BEAMIT Group, ZARE has now acquired a majority stake in the additive manufacturing (AM) medical company Proxera. As a result of this acquisition, one of the leading metal AM service providers in Europe will now also enter the high-growth market for 3D printed metal implants.
Scientists from medical tech company Fluicell have partnered with clinical R&D firm Cellectricon and the Swedish Karolinska Institutet university to 3D bioprint neural cells into complex patterns.
Aprecia Pharmaceuticals, the company behind the first FDA approved 3D printed drug Spritam, has entered into a long-term collaboration with private non-profit research and development (R&D) firm, Battelle.
Italian biomedical start-up Exos has debuted its new ‘Armor’ range of customizable 3D printed back braces at the online CES 2021 technology trade show.
Austrian startup Luxinergy developed a new material and a fast DLP 3D printer addressing two major challenges in the field of orthotics: comfort and speed. This innovation was made possible through advancements in materials science and DLP technology.
Last month, researchers at Carnegie Mellon University’s College of Engineering and the University of Pittsburgh’s School of Medicine demonstrated a 3D printed microneedle array platform capable of delivering vaccines directly into the skin, with the particular goal of improving COVID-19 vaccine delivery in the developing world. The study was conducted using micro-stereolithography PμSL 3D printing technology developed by Boston Micro Fabrication and is the latest effort in a race to the most precise 3D prints to produce objects used in our macroscopic world.
Population aging is one of Europe’s great challenges in the 21st century. By 2024, 22% of Europeans are expected to be over 65. Patients suffering from chronic joint detop fects or defects in the oral and maxillofacial regions have a significantly reduced quality of life and are continually dependent on health care. The Covid-19 crisis has shown how dangerous chronically overcrowded hospitals and large cohorts of care-dependent and risk-grouped patients can become. Therefore, science and technology must work together to ensure that living longer can be synonymous with living well. INKplant, a project funded by the European Union H2020, was conceived to face this challenge and democratize its new solutions.
Electronic medical device manufacturer EMTEL has selected 3DGence 3D printers for its product prototyping and part supply.
Additive manufacturing and 3D scanning have been increasingly integrated within the healthcare sector. 3D Systems, in particular, has contributed significantly to the advancement of surgical procedures with this technology.
American multinational consumer goods company Procter & Gamble (P&G) has signed a 3D bioprinting research and development agreement with San Francisco biotechnology company Aether.